SIGKNOW
Diagnostic Solution Provider

Established in 2014, we are committed to improving the diagnostic experience of patients and healthcare professionals around the globe with innovative Digital Health ready solutions that enable precise diagnosis, early detection, and prevention.
Tomorrow is now — embodied with medical grade wearables, big data, AI-enabled algorithm, our 14-day continuous patch ECG technology, and Professional-reviewed ECG reports are supporting Cardiologists and Neurologists in Asia, and shifting the Arrhythmia Diagnosis paradigm in the Region.

OUR SERVICE

Unlock our primary solution for your heart – EZYPRO® Continuous ECG Monitor,
and colorectal condition screening at home – JustWipe® FOBT Kit.

We work and care for health professionals' workflow, and strive to satisfy the clinical need, enhance the testing convenience, optimize current modalities, and build up a harmonious doctor-patient relationship.
Certified ECG Analysis Center

Certified ECG Analysis Center

A sophisticated fusion of deep learning software and certified ECG analysts. Our quality and analysis competence follow international guidelines. EZYPRO® Reporting is praised by global cardiologists.
14-Day Continuous ECG Recording

14-Day Continuous ECG Recording

Extend the traditional 24-hour recording to 14-day continuous monitoring. The solution demonstrates high patient compliance and arrhythmia detection. EZYPRO® looks after your heart.
QUALITY AND CERTIFICATION
Thailand FDA
TFDA台灣衛福部
Afaq_ISO 27001
Czech SUKL
Singapore HSA
Malaysia MDA
US FDA
醫療器材GMP
Vietnam MOH
Indonesia MOH
CE歐盟認證
IMPORTANT MILESTONES
  • 2014
    Sigknow Biomedical Co., Ltd. founded in June Linkou, New Taipei City
  • 2016
    Setup HQ in Songshan Taipei
    EZYPRO® UG01 Pilot Production
  • 2017
    EZYPRO® UG01 TFDA & CE approved
    ISO 13485 certified
    EZYPRO® Software GMP certified
  • 2018
    Post Market Clinical Trials with Leading Medical Centers
    EZYPRO® UG01 : 2018 National Innovation Award
  • 2019
    UG01 Commercialization in Taiwan
    EZYPRO® UG02 TFDA approved
    EZYPRO® UG01 : 2019 National Innovation Award-the Excelsior Award
  • 2020
    Malaysia MDA listed : 1st Oversea Market followed by ASEAN expansion
    EZYPRO® UG02 CE approved
    EZYPRO® UG01 & JustWipe : 2021 Taiwan Excellence
  • 2021
    Czech SUKL listed : Start European Market Pilot
    ISO 27001 certified
    EZYPRO® UG02 : 2022 Taiwan Excellence
  • 2022
    FDA approved in June
準訊生醫EZYPRO<sup>®</sup>參與2018亞太心律醫學會學術會議(APHRS)
16
Jul.2021
Latest News

準訊生醫EZYPRO®參與2018亞太心律醫學會學術會議(APHRS)

準訊生醫EZYPRO®參與亞太心律醫學會學術會議,為心律不整診斷推廣貢獻心力,,協助醫師及病患及早確診治療心律不整。

準訊生醫「擦即測JustWipe<sup>®</sup>」致力打造大腸直腸癌檢測健康生活圈
15
Apr.2021
Company News

準訊生醫「擦即測JustWipe®」致力打造大腸直腸癌檢測健康生活圈

大腸直腸癌是國人癌症發生率的第一位,準訊生醫與長庚大學吳旻憲教授的研究團隊產學合作,開發創新的大腸直腸癌檢測工具「擦即測JustWipe®糞便潛血檢測片」

準訊生醫EZYPRO<sup>®</sup>參加2018年腦中風學會年會暨第三屆台灣亞太腦中風論壇
09
Nov.2018
Latest News

準訊生醫EZYPRO®參加2018年腦中風學會年會暨第三屆台灣亞太腦中風論壇

準訊生醫EZYPRO®於2018年11/9-11/11台北國際會議中心,參加2018年腦中風學會年會暨第三屆台灣亞太腦中風論壇,提供嶄新的早期確診心房顫動方案,提高不明原因腦中風診斷準確率。

準訊生醫潛血試紙獲2017國家新創獎肯定
14
Dec.2017
Company News

準訊生醫潛血試紙獲2017國家新創獎肯定

準訊生醫結合長庚大學醫工所產學團隊研發出一款以衛生紙為載體的糞便潛血檢測試紙-擦即測,衛生紙式的設計將糞便潛血檢測融入每日如廁的行為當中。

EZYPRO<sup>®</sup> received CE and TFDA Certificates
08
Aug.2017
Company News

EZYPRO® received CE and TFDA Certificates

EZYPRO® UG01 is approved by TFDA and CE in May and August respectively.

CONTACT US
CONTACT US
We'd like to hear from you!

Please Enable cookies to improve your user experience